Indeed, studies have shown that alterations in mitochondrial ribosomal protein L12 (MRPL12), essential for mitochondrial ribosome biogenesis, significantly reduce tumor cell growth in HCC cell lines and patient-derived organoids [42,43]. This evidence concerns the gene MRPL12 and neoplasm.